NCT01519986

Brief Summary

The purpose of this study is to evaluate the absorption of dietary supplement of vitamin D3 (cholecalciferol), through the variation of 25 (OH) D levels, as the fat content of the meal associated with the administration of the supplement.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2011

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2012

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 27, 2012

Completed
Last Updated

January 27, 2012

Status Verified

January 1, 2012

Enrollment Period

1 month

First QC Date

January 5, 2012

Last Update Submit

January 24, 2012

Conditions

Keywords

Vitamin DCholecalciferolSupplementationDietary SupplementsDietary Fats25-hydroxyvitamin D

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in serum 25(OH)D at 14 day after intervention

    25(OH)D response to supplemental vitamin D3

    Change from baseline in serum 25(OH)D at 14 days

Secondary Outcomes (1)

  • Change from baseline in Parathyroid hormone at 14 days after intervention

    Change from baseline in Parathyroid hormone at 14 days

Study Arms (3)

Low fat Meal

EXPERIMENTAL

50,000 UI vitamin D3 with low fat meal

Dietary Supplement: Vitamin D3Dietary Supplement: Placebo

Medium fat meal

EXPERIMENTAL

50,000 UI vitamin D3 with medium fat meal

Dietary Supplement: Vitamin D3Dietary Supplement: Placebo

High fat meal

EXPERIMENTAL

50,000 UI vitamin D3 with high fat meal

Dietary Supplement: Vitamin D3Dietary Supplement: Placebo

Interventions

Vitamin D3DIETARY_SUPPLEMENT

Supplement of vitamin D3

High fat mealLow fat MealMedium fat meal
PlaceboDIETARY_SUPPLEMENT

Placebo

High fat mealLow fat MealMedium fat meal

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Residents of the hospital clinics of Porto Alegre

You may not qualify if:

  • Don't drink milk
  • Obesity
  • Malnutrition
  • Liver disease
  • Kidney disease or diabetes
  • Use of dietary supplements containing calcium and vitamin D
  • Medications
  • Anticonvulsants
  • Barbiturates, or steroids.
  • Having performed a journey the last four months to locations near the Earth's equatorial plane, due to sun exposure that may have occurred during this period, or vacations planned during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Raimundo FV, Faulhaber GA, Menegatti PK, Marques Lda S, Furlanetto TW. Effect of High- versus Low-Fat Meal on Serum 25-Hydroxyvitamin D Levels after a Single Oral Dose of Vitamin D: A Single-Blind, Parallel, Randomized Trial. Int J Endocrinol. 2011;2011:809069. doi: 10.1155/2011/809069. Epub 2011 Dec 7.

    PMID: 22190928BACKGROUND
  • Avnur Z, Nathan I, Dvilansky A, Livne A. Plasma constituent (s) inhibiting platelet adhesiveness. Isr J Med Sci. 1977 Mar;13(3):264-71.

    PMID: 15956BACKGROUND

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Cholecalciferol

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Tania W Furlanetto, PhD

    Federal University of Health Science of Porto Alegre

    PRINCIPAL INVESTIGATOR
  • Gustavo AM Faulhaber, PhD

    Federal University of Health Science of Porto Alegre

    STUDY CHAIR
  • Fabiana V Raimundo, MD

    Federal University of Health Science of Porto Alegre

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master Degree

Study Record Dates

First Submitted

January 5, 2012

First Posted

January 27, 2012

Study Start

September 1, 2011

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

January 27, 2012

Record last verified: 2012-01